RA Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,666,667
| Closed | -$7.14M | – | 64 |
|
|
2025
Q1 | $7.14M | Hold |
4,666,667
| – | – | 0.12% | 71 |
|
|
2024
Q4 | $11.6M | Buy |
+4,666,667
| New | +$11.6M | 0.15% | 71 |
|
|
2023
Q4 | – | Sell |
-4,398,453
| Closed | -$30.1M | – | 63 |
|
|
2023
Q3 | $30.1M | Hold |
4,398,453
| – | – | 0.59% | 44 |
|
|
2023
Q2 | $45.6M | Hold |
4,398,453
| – | – | 0.86% | 34 |
|
|
2023
Q1 | $35.6M | Hold |
4,398,453
| – | – | 0.81% | 38 |
|
|
2022
Q4 | $69.3M | Hold |
4,398,453
| – | – | 1.41% | 24 |
|
|
2022
Q3 | $69.2M | Hold |
4,398,453
| – | – | 1.48% | 21 |
|
|
2022
Q2 | $61.4M | Buy |
4,398,453
+2,580,645
| +142% | +$36M | 1.64% | 17 |
|
|
2022
Q1 | $31.3M | Buy |
+1,817,808
| New | +$31.3M | 0.68% | 45 |
|
|
2016
Q4 | – | Sell |
-1,547,152
| Closed | -$39.6M | – | 28 |
|
|
2016
Q3 | $39.6M | Sell |
1,547,152
-1,080,567
| -41% | -$27.7M | 4.09% | 8 |
|
|
2016
Q2 | $48.5M | Hold |
2,627,719
| – | – | 6.72% | 5 |
|
|
2016
Q1 | $49.8M | Buy |
2,627,719
+63,166
| +2% | +$1.2M | 6.36% | 4 |
|
|
2015
Q4 | $69.1M | Buy |
+2,564,553
| New | +$69.1M | 6.84% | 5 |
|